The European Commission: "Most of the participants in the studies [conducted by AstraZeneca] were between 18 and 55 years old. There are not yet enough results in older participants (over 55 years old) to provide a figure for how well the vaccine will work in this group."
THE EUROPEAN MEDICINES AGENCY: WHY RESIDENTS AND CITIZENS OF THE EUROPEAN UNION CAN TRUST THE COVID-19 VACCINE »
The European Medicines Agency (EMA) has recommended the granting of a conditional marketing of the vaccine Comirnaty, developed by BioNTech and Pfizer, to prevent COVID-19 in people from 16 years of age. EMA’s scientific opinion has paved the way for the first marketing authorisation of a COVID-19 vaccine in the EU by the European Commission. In fact, on 21 December 2020, the European Commission authorised that marketing.